Separately, HC Wainwright reissued a “buy” rating and set a $125.00 price target on shares of Neovasc in a research report on Friday, March 11th.
NVCN stock opened at $5.78 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 12.88 and a quick ratio of 12.50. The company has a market capitalization of $15.65 million, a PE ratio of -0.48 and a beta of 2.48. The firm’s 50-day moving average is $11.28 and its 200 day moving average is $12.42. Neovasc has a 12 month low of $4.64 and a 12 month high of $28.25.
A number of large investors have recently made changes to their positions in NVCN. Goldman Sachs Group Inc. acquired a new stake in shares of Neovasc during the second quarter worth $70,000. Citadel Advisors LLC increased its position in shares of Neovasc by 60.5% during the second quarter. Citadel Advisors LLC now owns 118,434 shares of the medical equipment provider’s stock worth $109,000 after acquiring an additional 44,641 shares during the last quarter. UBS Group AG grew its stake in Neovasc by 564.9% in the third quarter. UBS Group AG now owns 34,701 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 29,482 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Neovasc in the fourth quarter valued at approximately $67,000. Finally, Susquehanna International Group LLP acquired a new position in Neovasc in the fourth quarter valued at approximately $26,000. Hedge funds and other institutional investors own 2.42% of the company’s stock.
Neovasc Company Profile (Get Rating)
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.
- Get a free copy of the StockNews.com research report on Neovasc (NVCN)
- These Are the Three (3) Most Upgraded Stocks For Q2
- MarketBeat: Week in Review 5/23 – 5/27
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.